Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ratjen

Showing results (211-220 of 326) with videos related to

Pageof 33
Sort By:
Pediatrics|October 14, 2017
False-Positive Newborn Screening for Cystic Fibrosis and Health Care UseRobin Z Hayeems, Fiona A Miller, Marian Vermeulen, et al.
ERJ Open Research|March 18, 2026
Utility of hyperpolarised xenon-129 magnetic resonance imaging in primary ciliary dyskinesiaWallace B Wee, Brandon Zanette, Samal Munidasa, et al.
The Lancet. Respiratory Medicine|June 14, 2017
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trialFelix Ratjen, Christopher Hug, Gautham Marigowda, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 14, 2014
Lung arginase expression and activity is increased in cystic fibrosis mouse modelsThomas Jaecklin, Julia Duerr, Hailu Huang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 13, 2015
Alternative outcomes for the multiple breath washout in children with CFSanja Stanojevic, Renee Jensen, Dasiga Sundaralingam, et al.
The Lancet. Respiratory Medicine|May 9, 2021
Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension studyJordana E Hoppe, Mark Chilvers, Felix Ratjen, et al.
Pediatric Neurology|February 17, 2022
Neurovascular Manifestations in Pediatric Patients With Hereditary Haemorrhagic TelangiectasiaRoxana Azma, Adam A Dmytriw, Asthik Biswas, et al.
Chest|May 19, 2012
Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosaFelix Ratjen, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 14, 2013
Pulmonary exacerbations in CF patients with early lung diseaseMichael Anstead, Lisa Saiman, Nicole Mayer-Hamblett, et al.
The Journal of Pediatrics|December 27, 2011
Utility of contrast echocardiography for pulmonary arteriovenous malformation screening in pediatric hereditary hemorrhagic telangiectasiaSuhail Al-Saleh, Andreea Dragulescu, David Manson, et al.
Pageof 33

Showing results (211-220 of 326) with videos related to

Sort By:
Pageof 33
Pediatrics|October 14, 2017
False-Positive Newborn Screening for Cystic Fibrosis and Health Care UseRobin Z Hayeems, Fiona A Miller, Marian Vermeulen, et al.
ERJ Open Research|March 18, 2026
Utility of hyperpolarised xenon-129 magnetic resonance imaging in primary ciliary dyskinesiaWallace B Wee, Brandon Zanette, Samal Munidasa, et al.
The Lancet. Respiratory Medicine|June 14, 2017
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trialFelix Ratjen, Christopher Hug, Gautham Marigowda, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 14, 2014
Lung arginase expression and activity is increased in cystic fibrosis mouse modelsThomas Jaecklin, Julia Duerr, Hailu Huang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 13, 2015
Alternative outcomes for the multiple breath washout in children with CFSanja Stanojevic, Renee Jensen, Dasiga Sundaralingam, et al.
The Lancet. Respiratory Medicine|May 9, 2021
Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension studyJordana E Hoppe, Mark Chilvers, Felix Ratjen, et al.
Pediatric Neurology|February 17, 2022
Neurovascular Manifestations in Pediatric Patients With Hereditary Haemorrhagic TelangiectasiaRoxana Azma, Adam A Dmytriw, Asthik Biswas, et al.
Chest|May 19, 2012
Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosaFelix Ratjen, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 14, 2013
Pulmonary exacerbations in CF patients with early lung diseaseMichael Anstead, Lisa Saiman, Nicole Mayer-Hamblett, et al.
The Journal of Pediatrics|December 27, 2011
Utility of contrast echocardiography for pulmonary arteriovenous malformation screening in pediatric hereditary hemorrhagic telangiectasiaSuhail Al-Saleh, Andreea Dragulescu, David Manson, et al.
Pageof 33